SynthesisJournal of hepatology2023

Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis.

Won-Mook Choi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.